Clinical Trial Update: Study to Evaluate the Immunogenicity and Reactogenicity of a Booster Dose of GSK2036874A Vaccine in Healthy Toddlers [Phase 2]

View source ↗

Summary

Phase 2 trial assessing immunogenicity and reactogenicity of a booster dose of GSK2036874A vaccine in healthy toddlers; study completed with results posted in 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diphtheria
• Haemophilus Influenzae Type Disease
• Poliomyelitis
• Tetanus

Drugs mentioned

• GSK2036874A

Snippet

Sponsor: GlaxoSmithKline | Conditions: Haemophilus Influenzae Type b, Tetanus | Phase 2 | Status: COMPLETED | Results posted: 2017-04-12